Abstract
A novel oriP/EBNA1-based episomal vector has been constructed that persists episomally in cultured murine fibroblasts. The vector, pBH148, is equipped with the entire 185-kb human β-globin gene locus. After amplification in bacteria, column-purified episomal pBH148 was transfected into both cultured EBNA1-expressing human D98/Raji positive control fusion cells (DRpBH148) and cultured EBNA1-negative murine fibroblast cells (A9pBH148). Cell cultures were maintained concurrently with and without hygromycin selection for a period of 3 months. We show long-term stable episome maintenance of the full-size 200-kb circular double-stranded pBH148 in both the DRpBH148 cultures and the A9pBH148 cultures, regardless of selective pressure by agarose gel electrophoresis and Southern blot. EBNA1 transgene was detected by PCR in all transfected cultures. In addition, we were able to detect correctly spliced human β-globin mRNA by RT-PCR in all transfected late-passage DRpBH148 and A9pBH148 cell cultures. These findings illustrate that this oriP/EBNA1-based episomal vector is stable in a previously nonpermissive murine cell line and is a potential vector for human gene therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Anderson WF . Human gene therapy Nature 1998 392: 25–30
Naviaux RK, Verma IM . Retroviral vectors for persistent expression in vivo Curr Opin Biotechol 1992 3: 540–547
Drittanti L et al. Optimised helper virus-free production of high-quality adeno-associated virus vectors J Gene Med 2001 3: 59–71
Vos J-M . The simplicity of complex MACs Nature Biotechnol 1997 15: 1257–1259
Hartigan-O'Connor D, Amalfitano A, Chamberlain JS . Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polmerase J Virol 1999 73: 7835–7841
Vos J-M . Mammalian artificial chromosomes as tools for gene therapy Curr Opin Genet Develop 1998 8: 351–359
Vos J-M . Therapeutic mammalian artificial episomal chromosomes Curr Opin Mol Ther 1999 1: 204–205
Simpson K, McGuigan A, Huxley C . Stable episomal maintenance of yeast artificial chromosomes in human cells Mol Cell Biol 1996 16: 5117–5126
Sun T-Q, Fenstermacher D, Vos J-M . Human artificial episomal chromosomes for cloning large DNA in human cells Nature Genet 1994 8: 33–41
Westphal EM et al. A system for shuttling 200 kb BAC/PAC clones into human cells: stable extrachromosomal persistence and long-term ectopic gene activation Hum Gene Ther 1998 9: 1863–1873
Baichwal VR, Sugden B . Vectors for gene transfer derived from animal DNA viruses: transient and stale expression of transfected genes Kucherlapati R (eds); Gene Transfer Plenum Press 1986 pp 148–177
Ohe Y, Saijo N, Podack ER . Construction of a novel bovine papillomavirus vector without detectable transforming activity suitable for gene transfer Hum Gene Ther 1995 6: 325–333
Featherstone T, Huxley C . Extrachromosomal maintenance and amplification of yeast artificial chromosome DNA in mouse cells Genomics 1993 17: 267–278
Nonet GH, Wahl GM . Introduction of YACs containing a putative mammalian replication origin into mammalian cells can generate structures that replicate autonomously Somat Cell Mol Genet 1993 19: 171–192
Harrington JJ et al. Formation of de novo centromeres and construction of first-generation human artificial microchromosomes Nature Genet 1997 15: 345–355
Ikeno M et al. Construction of YAC-based mammalian artificial chromosomes Nature Biotechnol 1998 16: 431–439
Krysan PJ, Haase SB, Calos MP . Isolation of human sequences that replicate autonomously in human cells Mol Cell Biol 1989 9: 1026–1033
Wohlgemuth JG et al. Long-term gene expression from autonomously replicating vectors in mammalian cells Gene Therapy 1996 3: 503–512
Kelleher ZT et al. Epstein-Barr-based episomal chromosomes shuttle 100 kb of self-replicating circular human DNA in mouse cells Nature Biotechnol 1998 16: 762–768
Calos MP . The potential of extrachromosomal replicating vectors for gene therapy Trends Genet 1996 12: 463–466
Cooper M et al. Safety-modified episomal vectors for human gene therapy Proc Natl Acad Sci USA 1997 94: 6450–6455
Verma IM, Somia N . Gene therapy: promises. Problems Prospects Nature 1997 389: 239–242
Lui D, Saltzman WM . Synthetic DNA delivery systems Nature Biotechnol 2000 18: 33–37
Mountain A . Gene therapy: the first decade Trends Biotechnol 2000 18: 119–128
Yates JL, Warren N, Reisman D, Sugden BA . A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells Proc Natl Acad Sci USA 1984 81: 3806–3810
Wendelburg BJ, Vos J-M . An enhanced EBNA1 variant with reduced GLY-ALA domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells Gene Therapy 1998 5: 1389–1399
DuBridge RB et al. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system Mol Cell Biol 1987 7: 379–387
DuBridge RB, Calos MP . Recombinant shuttle vectors for the study of mutation in mammalian cells Mutagenesis 1988 3: 1–9
Belt PBGM et al. Efficient cDNA cloning by direct phenotypic correction of a mutant human cell line (HPRT2) using an Epstein-Barr virus-derived cDNA expression vector Nucleic Acids Res 1991 19: 4861–4866
Mazda O, Satoh E, Yasutomi K, Imanishi J . Extremely efficient gene transfection into lympho-hematopoietic cell lines by Epstein-Barr virus-based vectors J Immunol Meth 1997 204: 143–151
Banerjee S, Livanos E . Vos J.-M. Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus Nature Med 1995 1: 1303–1308
Yates JL, Warren N, Sugden B . Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells Nature 1985 313: 812–815
Lindenboim L, Anderson D, Stein R . The use of Epstein-Barr virus-based shuttle vectors in rat PC12 cells Cell Mol Neurobiol 1997 17: 119–127
Tsukamoto H et al. Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice Gene Therapy 1999 6: 1331–1335
Stoll SM, Sclimenti CR, Baba EJ . Epstein-Barr virus/human vector provides high-level, long-term expression of α1-antitrypsin in mice Mol Therapy 2001 4: 122–129
Sun TQ, Livanos E, Vos J-M . Engineering a mini-herpesvirus as a general strategy to transduce up to 180 kb of functional self-replicating human mini-chromosomes Gene Therapy 1996 3: 1081–1088
Little RD, Schildkraut CL . Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin Mol Cell Biol 1995 15: 2893–2903
Aladjem MI et al. Participation of the human beta-globin locus control region in initiation of DNA replication Science 1995 270: 815–819
Sierakowska H, Sambade MJ, Agrawal S, Kole R . Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides Proc Natl Acad Sci USA 1996 93: 12840–12844
Perou CM, Justice MJ, Pryor RJ, Kaplan J . Complementation of the beige mutation in cultured cells by episomally replicating murine yeast artificial chromosomes Proc Natl Acad Sci USA 1996 93: 5905–5909
Ellis J, Pannell D . The beta-globin locus control region versus gene therapy vectors: a struggle for expression Clin Genet 2001 59: 17–24
Yates JL . Epstein-Barr virus DNA replication DePamphilis ML (eds); DNA Replication in Eukaryotic Cells Cold Spring Harbor Press 1996 pp 751–773
Krysan PJ, Calos MP . Epstein-Barr virus-based vectors that replicate in rodent cells Gene 1993 136: 137–143
DePamphilis ML . Origins of DNA replication DePamphilis ML (eds); DNA Replication in Eukaryotic Cells Cold Spring Harbor Press 1996 pp 45–87
Lutfalla G, Armbruster L, Dequin S, Bertolotti R . Construction of an EBNA-producing line of well-differentiated human hepatoma cells and of appropriate Epstein-Barr virus-based shuttle vectors Gene 1989 76: 27–39
Langle-Rouault F et al. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids J Virol 1998 72: 6181–6185
Horlick RA et al. Combinatorial gene expression using multiple episomal vectors Gene 2000 243: 187–194
May C et al. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin Nature 2000 406: 82–86
Dalle B et al. Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts Gene Therapy 1999 6: 157–161
Payen E et al. Improvement of mouse beta-thalassemia by electrotransfer of erythropoietin cDNA Exp Hematol 2001 29: 295–300
Bohl D et al. Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle Blood 2000 95: 2793–2798
Peterson KR . Production and analysis of transgenic mice containing yeast artificial chromosomes Genetic Engineer 1997 19: 235–255
Dillon N, Grosveld F . Chromatin domains as potential units of eukaryotic gene function Curr Opin Genet Dev 1994 4: 260–264
Wolffe AP . Chromatin structure and DNA replication: implications for transcriptional activity DePamphilis ML (eds); DNA Replication in Eukaryotic Cells Cold Spring Harbor Press 1996 pp 271–293
Mucke S et al. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells Gene Therapy 1997 4: 82–92
Garret M, McHendry RB, Spickofsky N, Margolskee RF . Isolation of a clone which induces expression of the gene encoding the human tumor necrosis factor receptor Gene 1992 111: 215–222
Fichard A et al. Human recombinant alpha 1 (V) collagen chain. Homo-trimeric assembly and subsequent processing J Biol Chem 1997 272: 30083–30087
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Black, J., Vos, JM. Establishment of an oriP/EBNA1-based episomal vector transcribing human genomic β-globin in cultured murine fibroblasts. Gene Ther 9, 1447–1454 (2002). https://doi.org/10.1038/sj.gt.3301808
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301808
Keywords
This article is cited by
-
Resource-aware construct design in mammalian cells
Nature Communications (2023)
-
The infectious BAC genomic DNA expression library: a high capacity vector system for functional genomics
Scientific Reports (2016)
-
Development of a Hybrid Baculoviral Vector for Sustained Transgene Expression
Molecular Therapy (2009)
-
Advances in High-capacity Extrachromosomal Vector Technology: Episomal Maintenance, Vector Delivery, and Transgene Expression
Molecular Therapy (2008)
-
Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element
Gene Therapy (2006)